Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis.
Deivasigamani S, Orabi H, El-Shafei A, Adams ES, Kotamarti S, Aminsharifi A, Davis L, Wu Y, J SJ, Polascik TJ. Deivasigamani S, et al. Among authors: orabi h. Prostate. 2023 Oct;83(14):1373-1386. doi: 10.1002/pros.24600. Epub 2023 Jul 19. Prostate. 2023. PMID: 37469120
Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: A Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes.
Campbell SP, Deivasigamani S, Arcot R, Adams ES, Orabi H, Elshafei A, Tan WP, Davis L, Wu Y, Chang A, Jones JS, Polascik TJ. Campbell SP, et al. Among authors: orabi h. Clin Genitourin Cancer. 2023 Oct;21(5):555-562. doi: 10.1016/j.clgc.2023.06.015. Epub 2023 Jun 28. Clin Genitourin Cancer. 2023. PMID: 37438234
Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.
Orabi H, Howard L, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Janes JL, Freedland SJ, Polascik TJ. Orabi H, et al. Eur Urol Open Sci. 2022 Feb 10;37:106-112. doi: 10.1016/j.euros.2022.01.003. eCollection 2022 Mar. Eur Urol Open Sci. 2022. PMID: 35243395 Free PMC article.
Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, Rosette J, Polascik TJ; Focal Therapy Group Authors. Tan WP, et al. Urol Oncol. 2021 Nov;39(11):781.e17-781.e24. doi: 10.1016/j.urolonc.2021.01.027. Epub 2021 Mar 4. Urol Oncol. 2021. PMID: 33676851 Free PMC article.
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society.
Marra G, Laguna MP, Walz J, Pavlovich CP, Bianco F, Gregg J, Lebastchi AH, Lepor H, Macek P, Rais-Bahrami S, Robertson C, Rukstalis D, Salomon G, Ukimura O, Abreu AL, Barbe Y, Cathelineau X, Gandaglia G, George AK, Gomez Rivas J, Gupta RT, Lawrentschuk N, Kasivisvanathan V, Lomas D, Malavaud B, Margolis D, Matsuoka Y, Mehralivand S, Moschini M, Oderda M, Orabi H, Rastinehad AR, Remzi M, Schulman A, Shin T, Shiraishi T, Sidana A, Shoji S, Stabile A, Valerio M, Tammisetti VS, Phin Tan W, VAN DEN Bos W, Villers A, Willemse PP, DE LA Rosette J, Polascik T, Sanchez-Salas R; Focal Therapy Society. Marra G, et al. Among authors: orabi h. Minerva Urol Nephrol. 2022 Oct;74(5):581-589. doi: 10.23736/S2724-6051.20.04160-0. Epub 2021 Jan 13. Minerva Urol Nephrol. 2022. PMID: 33439577 Free article.
32 results